FAST NEWS: InnoCare Pharma Losses Double on Higher Costs And Exchange Deficit
The latest: InnoCare Pharma Ltd. (9969.HK) issued a profit warning Friday, estimating a net loss of no more than 495 million yuan ($73 million) for the first half of this year,…
RELATED ARTICLES
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK -
BRIEF: InnoCare revenue jumps 37% in 2024 on strong lymphoma drug sales
9969.HK 688428.SHG
-
Blue Moon shadowed by aggressive promotional spending in slowing economy
6993.HK
-
Yalla revenue growth returns to double-digits ahead of new gaming push
YALA.US
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
-
Could consumer stimulus send Li Ning stock vaulting higher?
2331.HK
